Stay updated on VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.

Latest updates to the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding/status notice (Revision: v3.4.1). These changes do not affect the study content or user interactions on the page.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a site-wide notice that information may not be up to date due to a lapse in government funding, with guidance to check opm.gov for updates. Updated page revision to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded UI element 'Show glossary' and new metadata labels ('Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', 'Revision: v3.4.0'); removed outdated labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').SummaryDifference0.1%

- Check62 days agoChange DetectedThe change log shows a minor version update from v3.3.3 to v3.3.4. No changes to study content, navigation, or critical data are evident in the screenshot; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations were expanded to include new sites across Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New York, North Carolina, Pennsylvania, Texas, Utah, Virginia, Washington, Wisconsin, Alberta, and Ontario. The page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference2%

Stay in the know with updates to VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.